Business Description
Accelerate Diagnostics Inc
NAICS : 325413
SIC : 5047
ISIN : US00430H2013
Share Class Description:
MEX:AXDX: Ordinary SharesDescription
Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Accelerate Diagnostics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 218.668 | ||
| EPS (TTM) (MXN) | -40.565 | ||
| Beta | -1.5398 | ||
| 3-Year Sharpe Ratio | -1 | ||
| 3-Year Sortino Ratio | -1.06 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (MXN) | - | ||
| 20-Day SMA (MXN) | 1.75 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (MXN) | 1.75 - 1.75 | ||
| Shares Outstanding (Mil) | 25.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Accelerate Diagnostics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Accelerate Diagnostics Inc Stock Events
| Event | Date | Price (MXN) | ||
|---|---|---|---|---|
| Fourth quarter earnings results for 2026 | 2027-02-15 | In 159 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 65 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-13 | In 65 days | ||
| Second quarter earnings conference call for 2026 | 2026-09-14 | In 5 days | ||
| Second quarter earnings results for 2026 | 2026-09-14 | In 5 days | ||
| General meeting for 2025 | 2026-09-08 | 1.75 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-15 16:30 | 1.75 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-15 | 1.75 (+0.00%) | ||
| Annual report for 2025 | 2026-03-20 | 1.75 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-20 | 1.75 (+0.00%) |
Show
Entries
Accelerate Diagnostics Inc Frequently Asked Questions
What is Accelerate Diagnostics Inc(MEX:AXDX)'s stock price today?
The current price of MEX:AXDX is MXN1.75. The 52 week high of MEX:AXDX is MXN1.75 and 52 week low is MXN1.75.
When is next earnings date of Accelerate Diagnostics Inc(MEX:AXDX)?
The next earnings date of Accelerate Diagnostics Inc(MEX:AXDX) is 2026-09-14 Est..
Does Accelerate Diagnostics Inc(MEX:AXDX) pay dividends? If so, how much?
Accelerate Diagnostics Inc(MEX:AXDX) does not pay dividend.
Press Release
Articles on Accelerate Diagnostics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers